X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HUL - Comparison Results

HUL 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HUL AMAR REMEDIES/
HUL
 
P/E (TTM) x -0.5 61.8 - View Chart
P/BV x 0.1 47.5 0.1% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 AMAR REMEDIES   HUL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HUL
Mar-19
AMAR REMEDIES/
HUL
5-Yr Chart
Click to enlarge
High Rs1641,871 8.8%   
Low Rs861,322 6.5%   
Sales per share (Unadj.) Rs261.6181.6 144.1%  
Earnings per share (Unadj.) Rs17.428.0 62.1%  
Cash flow per share (Unadj.) Rs22.330.6 72.8%  
Dividends per share (Unadj.) Rs022.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs100.736.3 277.1%  
Shares outstanding (eoy) m26.162,164.53 1.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.58.8 5.4%   
Avg P/E ratio x7.257.0 12.6%  
P/CF ratio (eoy) x5.652.1 10.8%  
Price / Book Value ratio x1.243.9 2.8%  
Dividend payout %078.6 0.0%   
Avg Mkt Cap Rs m3,2703,454,698 0.1%   
No. of employees `000NA5.6 0.0%   
Total wages/salary Rs m16318,750 0.9%   
Avg. sales/employee Rs ThNM69,636.8-  
Avg. wages/employee Rs ThNM3,321.5-  
Avg. net profit/employee Rs ThNM10,735.2-  
INCOME DATA
Net Sales Rs m6,844393,100 1.7%  
Other income Rs m215,500 0.4%   
Total revenues Rs m6,865398,600 1.7%   
Gross profit Rs m1,13188,800 1.3%  
Depreciation Rs m1285,650 2.3%   
Interest Rs m398330 120.6%   
Profit before tax Rs m62688,320 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,280 2.2%   
Tax Rs m12125,440 0.5%   
Profit after tax Rs m45560,600 0.8%  
Gross profit margin %16.522.6 73.2%  
Effective tax rate %19.328.8 67.1%   
Net profit margin %6.615.4 43.1%  
BALANCE SHEET DATA
Current assets Rs m4,904119,140 4.1%   
Current liabilities Rs m3,58186,670 4.1%   
Net working cap to sales %19.38.3 234.0%  
Current ratio x1.41.4 99.6%  
Inventory Days Days12424 519.9%  
Debtors Days Days10017 594.0%  
Net fixed assets Rs m1,68951,210 3.3%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35876,510 3.1%   
Net worth Rs m2,63578,670 3.3%   
Long term debt Rs m5070-   
Total assets Rs m6,862186,290 3.7%  
Interest coverage x2.6268.6 1.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.1 47.3%   
Return on assets %12.432.7 38.0%  
Return on equity %17.377.0 22.4%  
Return on capital %31.0109.8 28.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2733,240 8.4%   
Fx outflow Rs m213,820 0.0%   
Net fx Rs m271-10,580 -2.6%   
CASH FLOW
From Operations Rs m-31358,000 -0.5%  
From Investments Rs m-489-4,380 11.2%  
From Financial Activity Rs m769-53,900 -1.4%  
Net Cashflow Rs m-33-280 11.6%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   LINC PEN & PLASTICS  ARCHIES LTD  GILLETTE INDIA  EMAMI LTD  KARUTURI GLOBAL  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

HUL 2018-19 Annual Report Analysis (Annual Result Update)

Jun 7, 2019 | Updated on Jun 7, 2019

Here's an analysis of the annual report of HUL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of HUL. Also includes updates on the valuation of HUL.

HUL Announces Quarterly Results (4QFY19); Net Profit Up 13.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, HUL has posted a net profit of Rs 15 bn (up 13.8% YoY). Sales on the other hand came in at Rs 99 bn (up 9.3% YoY). Read on for a complete analysis of HUL's quarterly results.

HUL Announces Quarterly Results (3QFY19); Net Profit Up 8.9% (Quarterly Result Update)

Jan 18, 2019 | Updated on Jan 18, 2019

For the quarter ended December 2018, HUL has posted a net profit of Rs 14 bn (up 8.9% YoY). Sales on the other hand came in at Rs 96 bn (up 11.3% YoY). Read on for a complete analysis of HUL's quarterly results.

HIND. UNILEVER Announces Quarterly Results (2QFY19); Net Profit Up 19.5% (Quarterly Result Update)

Oct 15, 2018 | Updated on Oct 15, 2018

For the quarter ended September 2018, HIND. UNILEVER has posted a net profit of Rs 15 bn (up 19.5% YoY). Sales on the other hand came in at Rs 92 bn (up 11.1% YoY). Read on for a complete analysis of HIND. UNILEVER's quarterly results.

HIND. UNILEVER 2017-18 Annual Report Analysis (Annual Result Update)

Aug 9, 2018 | Updated on Aug 9, 2018

Here's an analysis of the annual report of HIND. UNILEVER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of HIND. UNILEVER. Also includes updates on the valuation of HIND. UNILEVER.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS